|
Original
Contribution - September 2000 - Volume 95, Number 9
- Pages 2285-2295
Enterocolitis
in Children With Developmental Disorders
A.
J. Wakefield, F.R.C.S.,a,b
A. Anthony, M.Sc., Ph.D., M.B.B.S.,b
S. H. Murch, Ph.D., F.R.C.P., F.R.C.P.C.H.,b
M. Thomson, MB.ChB., M.R.C.P., F.R.C.P.C.H.,c
S. M. Montgomery, Ph.D.,c
S. Davies, M.R.C.Path.,b
J. J. O'Leary, M.D., D.Phil., M.R.C.Path.,b
M. Berelowitz, F.R.C.Psych.,e
and J. A. Walker-Smith, M.D., F.R.C.P., F.R.A.C.P., F.R.C.P.C.H.d
OBJECTIVE:
Intestinal pathology, i.e., ileocolonic lymphoid nodular
hyperplasia (LNH) and mucosal inflammation, has been described in
children with developmental disorders. This study describes some
of the endoscopic and pathological characteristics in a group of
children with developmental disorders (affected children) that are
associated with behavioral regression and bowel symptoms, and
compares them with pediatric controls.
METHODS:
Ileocolonoscopy and biopsy were performed on 60 affected children
(median age 6 yr, range 3-16; 53 male). Developmental diagnoses
were autism (50 patients), Asperger's syndrome (five),
disintegrative disorder (two), attention deficit hyperactivity
disorder (ADHD) (one), schizophrenia (one), and dyslexia (one).
Severity of ileal LNH was graded (0-3) in both affected children
and 37 developmentally normal controls (median age 11 yr, range
2-13 yr) who were investigated for possible inflammatory bowel
disease (IBD). Tissue sections were reviewed by three pathologists
and scored on a standard proforma. Data were compared with
ileocolonic biopsies from 22 histologically normal children (controls)
and 20 children with ulcerative colitis (UC), scored in an
identical manner. Gut pathogens were sought routinely.
RESULTS:
Ileal LNH was present in 54 of 58 (93%) affected children and in
five of 35 (14.3%) controls (p < 0.001). Colonic LNH was
present in 18 of 60 (30%) affected children and in two of 37
(5.4%) controls (p < 0.01). Histologically, reactive
follicular hyperplasia was present in 46 of 52 (88.5%) ileal
biopsies from affected children and in four of 14 (29%) with UC,
but not in non-IBD controls (p < 0.01). Active ileitis
was present in four of 51 (8%) affected children but not in
controls. Chronic colitis was identified in 53 of 60 (88%)
affected children compared with one of 22 (4.5%) controls and in
20 of 20 (100%) with UC. Scores of frequency and severity of
inflammation were significantly greater in both affected children
and those with UC, compared with controls (p < 0.001).
CONCLUSIONS:
A new variant of inflammatory bowel disease is present in this
group of children with developmental disorders.
Cite
this article as:
. Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM,
Davies S, O'Leary JJ, Phil D, Berelowitz M and Walker-Smith JA.
Enterocolitis in Children With Developmental Disorders. Am J
Gastroenterol September;95:2285-2295.
aUniversity
Departments of Medicine, bHistopathology, cPaediatric
Gastroenterology, and dPaediatric Psychiatry, Royal
Free and eUniversity College Medical School, Royal Free
Campus, London, United Kingdom, and University Department of
Pathology, Coombe Women's Hospital and Trinity College, Dublin,
Eire
Introduction
We
have recently described a characteristic pattern of intestinal
inflammation in a cohort of children with developmental disorders
(1).
In these children, the majority of whom had autism, a period of
initial normal development was followed by developmental
regression and loss of acquired skills, sometimes occurring
precipitously over a period of days to weeks. Long-standing
intestinal symptoms, as described previously (1),
were typical of this group of children. These symptoms had often
started at around the same time as the behavioral changes.
Ileocolonic
lymphoid nodular hyperplasia (LNH) was a consistent feature of
this condition, an observation that has been reported subsequently
in children with attention deficit hyperactivity disorder (ADHD)
and non-IgE-mediated food allergy (2).
There is an anecdotal impression that LNH is a common finding in
children undergoing ileocolonoscopy, although this has not been
subjected to systematic analysis in a controlled study. It cannot
be assumed that LNH is a normal finding in children, as
aymptomatic children are not subjected to ileocolonoscopy, and LNH
may produce symptoms in its own right (3).
Chronic intestinal LNH is a feature of either congenital or
acquired immunodeficient states (4,
5,
6,
7,
8,
9,
10)
and has been described in congenital B cell abnormalities (5,
6),
and common variable immunodeficiency (7,
8).
In its persistent acquired form, ileal LNH has been reported in
association with infection with human immunodeficiency virus (HIV)
before the development of AIDS (10).
The
other consistent feature of the intestinal lesion was a
mild-to-moderate colitis that lacked the specific diagnostic
features of either Crohn's disease or ulcerative colitis (1).
This combination of features, i.e., LNH and nonspecific
colitis, indicates the possibility of chronic mucosal and/or
systemic immune dysregulation. Systemic immunological
abnormalities are not infrequent in children with autistic
spectrum disorders (11,
12,
13,
14),
although the origin and significance of the findings are uncertain.
These immune changes, plus the presence of myelin basic protein (MBP)
antibodies (15)
and inhibition of macrophage migration to MBP (16),
have led some workers to suggest that the behavioural syndrome may
be associated with cerebral damage due to an autoimmune response
to myelin or other structural components of the CNS (15,
16).
As part of our initial study (1)
we undertook cerebral magnetic resonance imaging, EEG, and
biochemical analysis of cerebrospinal fluid; none of these
investigations indicated cerebral inflammation that would be
consistent with autoimmune demyelination, although a more subtle
lesion remains a possibility. Alternatively, others have proposed
that some forms of autism may arise from the toxic effects of
intestinal products on the developing brain (17,
18,
19),
a situation that may have some overlap with hepatic enephalopathy.
An early childhood enterocolitis would be more consistent with the
latter mechanism.
This
study sought to describe some of the characteristic endoscopic and
histopathological features of this syndrome in a larger cohort of
children with developmental disorders and intestinal symptoms, and
to compare the findings with those in developmentally normal
children undergoing ileocolonoscopy.
Materials
and Methods
This
study involved the analysis of data from 60 consecutive children
with developmental disorders (affected children) including those
12 children described in a preliminary report (1).
The median age of the children was 6 yr (range 3-16 yr) and 53
were boys, consistent with the male bias of developmental
disorders (20).
Developmental diagnoses in the affected children were autism (50
patients), Asperger's syndrome (five), disintegrative disorder (two),
attention deficit hyperactivity disorder (ADHD) (one), and
schizophrenia (one). The latter child was the oldest in the cohort,
at 14 yr of age. The remaining child in this cohort, a girl 8 yr
of age, had dyslexia and learning difficulties: she underwent
developmental regression from approximately 54 months of age,
which was associated with mouth ulcers, conjunctivitis, and severe
constipation. Her developmental status is currently under
investigation.
Autism
is a behavioral syndrome that consists of qualitative impairments
in social interaction and communication, with restrictive,
repetitive, and stereotypic patterns of behavior. Delays or
abnormal functioning in at least one of these areas occurs before
the age of 3 yr. Asperger's syndrome is a high-functioning
autistic spectrum disorder, and disintegrative disorder is a
regressive condition occurring at age >3 yr in a previously
normal child. Loss of acquired skills may occur precipitously or
over a period of months. The behavioral features are similar to
those of autism but may be accompanied by loss of bowel and
bladder control (20).
The
majority of affected children were white (57),
but two were of Middle-Eastern origin, and one child had an Indian
father and a white mother.
All
but three affected children had a developmental disorder that was
associated with a clear history of regression, with loss of
acquired skills after
1
year of documented normal development (general practitioner/health
visitor records). In three cases, affected children who had been
developmentally normal failed to progress beyond a certain point,
but did not regress. All but one of the affected children had
current intestinal symptoms consisting of abdominal pain,
constipation, diarrhea (or alternating constipation and diarrhea),
and bloating. The one affected child who did not have current
intestinal symptoms was investigated at his parents' and general
practitioner's request. Affected children were consistently
fastidious in their eating habits, with a diet limited largely to
cereals, potato crisps, and bread. Despite this, they typically
seemed well nourished, with anthropomorphic indices within normal
limits. Certain foodstuffs such as dairy products were reported by
parents to produce deterioration in behavior, whereas withholding
such foods apparently produced behavioral improvement—in
particular, for aggression, eye contact, and sleep pattern.
According to parental reports, recognizably undigested food was
often seen in stools.
Investigations
Medical
and developmental histories were taken, and a routine physical
examination was conducted. A fasting, morning blood sample was
taken for routine hematology and biochemistry. Sera were screened
for antigliadin and antiendomyseal antibodies. Common enteric
pathogens were sought by routine serology, microscopy, and
culture. A review of the children was undertaken by an experienced
child psychiatrist to confirm the developmental diagnosis using
DSM-IV criteria (20).
Ileocolonoscopy
and Histology
All
children underwent routine ileocolonoscopy and mucosal biopsy.
Ileal LNH was classified subjectively according to prominence and
extent as mild (grade 1), moderate (grade 2), or severe (grade 3),
or as grade 0 if the ileum showed no LNH (Fig.
1),
according to the report provided by one of three physicians.
Similarly, ileal appearances were graded in 37 developmentally
normal children (median age 11 yr, range 2-13 yr). All of these
children had been investigated for symptoms of possible
inflammatory bowel disease, although the final diagnosis was
neither Crohn's disease nor ulcerative colitis. Diagnoses in these
children included idiopathic constipation (five patients), polyps
(two), and LNH (five). In the majority (thirty), including those
with constipation, the colonoscopy was reported as normal, and
follow-up has not revealed any other abnormality.

Figure
1
Lymphoid nodular hyperplasia (LNH) of the terminal ileum in
affected children showing representative grades of LNH: (A)
none (score 0); (B) mild (score 1); (C) moderate
(score 2); and (D) severe (score 3).
Mucosal
biopsies were taken from the ileum, cecum/ascending colon,
transverse colon, descending/sigmoid colon, and rectum.
Hematoxylin and eosin-stained histological sections from all
biopsies were reviewed in the routine pathology laboratory,
followed by independent review and scoring on a standard proforma
(Table 1).
In those cases where there was disagreement between these two
reports, sections were examined and reported by a third senior
pathologist, whose arbitration provided the final score. In an
identical manner, histological sections from the ileum and colon
of children without developmental disorder were scored (median age
11.5 years; range 2-13). These included 22 consecutive
ileocolonoscopic biopsy series that had been reported as normal
after routine histopathology assessment. All children in this
non-IBD control group had undergone ileocolonoscopy for
investigation of intestinal symptoms and are included in the 37
endoscopic controls, as described above. To validate further the
evaluation and scoring, 10 coded ileocolonic biopsy series (five
affected children and five non-IBD controls) were reviewed at
another institution by a senior pathologist in an observer-blinded
fashion. Data from these independent assessments were compared.
Table
1.
Histopathology Proforma Used for Scoring of All Biopsies From
Affected Children (Autistic Enterocolitis), Non-IBD Controls, and
Those With Ulcerative Colitis
|
Histological
Grade
|
Normal
|
Mild
|
Moderate
|
Severe
|
|
Score
|
0
|
1
|
2
|
3
|
|
Acute inflammation
|
No
interstitial neutrophils in lamina propria (LP)
|
Interstitial
neutrophils in LP
|
Cryptitis
|
Crypt
abscesses
|
|
Chronic
inflammation
|
No
increase in LP mononuclear cells
|
Mild
increase with loss of stratification within LP
|
Moderate
increase
|
Severe
|
|
Epithelial/LP
changes
|
Normal
|
Disruption
of epithelial basal lamina.
|
Erosion
|
Ulceration
|
|
|
|
Condensation
of LP
|
|
|
|
Lymphoid
follicles
|
Normal
|
Reactive
changes: prominent germinal centres; tingible body
macrophages
|
Follicular
enlargement with confluence
|
Aphthoid
ulceration
|
|
Crypts
|
Normal
|
Bifid
glands
|
Glandular
disruption
|
Dysplasia
|
|
|
|
Goblet
cell depletion
|
Paneth
cell metaplasia
|
|
In
order to compare the site and degree of pathological changes in
biopsies from affected children with those of a well characterized
IBD, ileocolonic biopsy series from 20 children with established
ulcerative colitis (median age 14 yr, range 8-15 yr) were examined
and scored in an identical manner.
Selection
Criteria
To
avoid selection bias, children in all groups were chosen
consecutively on the basis that they fulfilled the primary
criteria; that is, developmental disorder with bowel symptoms,
developmentally normal with bowel symptoms, developmentally normal
with normal histology, or ulcerative colitis.
Ethical
Approval
All
clinical investigations were undertaken with fully informed,
written consent from the parents. The initial phase of these
studies (1)
was approved by the Ethical Practices Committee of the Royal Free
Hampstead NHS Trust. Thereafter, children were investigated
according to clinical need after a formal referral from each
child's General Practitioner or Consultant.
Statistical
Analysis
The
analyses were performed using SPSS 7.5 for Windows and EpiInfo
6.04b. The
2
test was used to investigate differences in endoscopic and
histopathological features between the affected children and the
control groups. Where any cell in the analysis contained five or
fewer subjects, two-tailed Fisher's exact test was used to assess
significance, to adjust for the potential effect of small numbers.
The Spearman rank correlation was used to investigate the
relationship between grade of LNH (0-3) and absolute lymphocyte
count among the affected children.
Results
Ileocolonoscopy
ILEUM.
Complete ileoscopy, in which the terminal ileum was visualized and
biopsied, was successful in 58 of 60 (97%) affected children and
in 35 of 37 (95%) non-IBD controls. The frequency and grade of
ileal LNH in these two patient groups is shown in Figure
2.
Representative grades of ileal LNH are shown in Figure
1.
The data demonstrate not only the consistent presence of LNH in
the ileum of affected children 54 of 58 (93%), but also its
relative infrequency in developmentally normal children undergoing
investigation for similar intestinal symptoms (five of 35; 14.3%);
this difference is statistically significant (p <
0.001). In affected children, 76% scored either moderate or
severe; in non-IBD controls, all five children with ileal LNH
scored either moderate (n = 4) or severe (n = 1). Of these five
controls, symptoms that were the indication for ileocolonoscopy
included chronic abdominal pain in four and change in bowel habit
in one; endoscopically, there was no other demonstrable pathology
to account for these symptoms.
 |
Figure
2
Percentage of children showing ileal lymphoid nodular hyperplasia
(LNH), comparing affected children
with developmentally normal children
, investigated for symptoms of inflammatory bowel disease, in whom the
final diagnosis was neither Crohn's disease nor ulcerative colitis.
LNH was significantly more common in affected children than in
controls (p < 0.001).
COLON.
Complete colonscopy was successful in all 60 (100%) of the
affected children and all 37 (100%) non-IBD controls. Colonscopies
were scored for either the presence or absence of the following:
LNH (not graded), red halo sign surrounding follicles (21),
loss of vascular pattern, mucosal granularity, mucosal erythema,
and presence of ulcer(s). These features, which are recognized
correlates of associated histopathological abnormality, were noted
previously to be characteristic of this patient group (1).
These features were recorded both for cases and for non-IBD
controls; the data are shown in Figure
3.
Colonic LNH was present in 18 of 60 (30%) affected children
compared with only two of 37 (5.4%) non-IBD controls (p
< 0.01). Similarly, of the other six endoscopic features
described above, all but ulceration are significantly more common
in affected children compared with controls (p < 0.05).
Although the mean age of the developmentally normal comparison
group was significantly greater than that of the affected children,
the presence or absence of LNH was not related to age in either
group.
 |
Figure
3
Colonoscopic features in affected children
and non-inflammatory bowel disease controls
. Colonoscopies were scored for either the presence or absence
of lymphoid nodular hyperplasia, red halo sign, loss of vascular
pattern (LVP), mucosal granularity, mucosal erythema, and
ulceration. All of the features except ulceration were
statistically significantly more common in affected children than
in controls (p < 0.01).
Histological
Findings
Ileal
and colonic biopsies from 60 affected children, 22 non-IBD control
children, and 20 children with ulcerative colitis were examined
initially by a clinical histopathologist, and were subsequently
evaluated and scored by another pathologist using a standard
proforma (Table
1).
In the 60 affected children, there was discordance between the two
reports in five cases: these were resolved by a third pathologist,
whose independent review agreed with the first pathologist in two
cases and the second pathologist in three cases. There was
disagreement between pathologists concerning the interpretation of
biopsies from only one of the non-IBD controls (which was resolved
as showing mild inflammation in a cecal biopsy) and in none of the
children with ulcerative colitis.
Ten
ileocolonic biopsy series were reviewed and scored in an
observer-blinded fashion at an independent institution. No
indication was given of how many samples came from each patient
group. Cases were clearly distinguished from controls by the
blinded reviewer. Out of a possible total of 15 points,
independent scores were identical for the same criterion in four
of 10 cases (40%), within one point of each other in five of 10
cases (50%), and within two points of each other in one of 10
cases (10%) (Spearman rank correlation 0.79; p < 0.006).
No reviewer scored systematically higher or lower than the other.
ILEAL
HISTOLOGY. A total of 86 ileal biopsies were assessed and scored.
This total comprised 52 biopsies from affected children (seven
biopsies, consisting of fragments of villi only, were considered
inadequate for evaluation), 20 from non-IBD controls, and 14 from
children with ulcerative colitis. Reactive follicular hyperplasia
(RFH) was identified in 47 of 51 (92%) biopsies from affected
children and in four of 14 (29%) with ulcerative colitis. It was
not present in any of the 20 biopsies from non-IBD controls. The
differences between biopsies from affected children and from both
non-IBD controls and those with ulcerative colitis are significant
(p < 0.001 and p < 0.01, respectively).
Qualitatively, ileal lymph nodes in those children with LNH showed
marked expansion of lymphoid tissue in histological section, as
described previously (1).
Follicle numbers per biopsy were increased from 2-3 follicles per
biopsy in normal ileal biopsies to 4-5 per biopsy in those with
LNH: follicles were confluent with loss of follicle-to-follicle
demarcation. In comparison with normal follicles, the germinal
centers were grossly enlarged and reactive, as indicated by
numerous tingible body macrophages. The outer margins of the T
cell zone were not well defined as they were in normal ileal
follicles, with the lymphoid compartment extending into, and
apparently expanding, adjacent villi. There was also disruption,
but not destruction, of adjacent crypts. Expansion of lymphoid
tissue around crypts gave the impression of a decrease in crypt
numbers, a histological appearance similar to that described by
Fiber and Schaefer (3).
In addition, neutrophils and lymphocytes were often seen
infiltrating the epithelium overlying follicles: neutrophils were
also seen infiltrating the crypt epithelium (acute cryptitis) in
some cases. Overall, active ileitis (neutrophilic infiltration)
was seen in four of 51 (8%) ileal biopsies from affected children.
Aphthoid ulceration was seen in two of 51 (4%) biopsies. In the 20
non-IBD control ileal biopsies, none showed active inflammation.
Only two (4%) biopsies from affected children scored positively
for the presence of an increase in intraepithelial lymphocytes,
and two (4%) for the presence of eosinophil infiltration of the
lamina propria. These features were not present in either non-IBD
or ulcerative colitis controls. These differences were not
statistically significant because of small numbers.
COLONIC
HISTOLOGY. A total of 380 colonic biopsies were examined and
scored; these included 229 biopsies from affected children, 80
from non-IBD controls, and 71 from children with ulcerative
colitis. The numbers and percentage of biopsies in each group
showing pathological changes are shown in Table 2 and
Figure
4,
respectively. Only one cecal biopsy in the non-IBD controls showed
evidence of inflammation, which was scored as mild. In contrast, a
high percentage of biopsies from throughout the colon showed
pathological changes in both affected children and those with
ulcerative colitis. The differences between both affected children
and those with ulcerative colitis and non-IBD controls, for the
proportion of biopsies exhibiting pathological change are, for
each site, significant (p < 0.001) (Table
2).
Inflammatory changes in biopsy series from individual affected
children, although distributed throughout the colon, were patchy.
Some of the histological characteristics of this colitis are shown
in Figure
5.
Overall, chronic inflammation was identified in colonic biopsies
from 53 of 60 (88%) affected children, compared with one of 22
(4.5%) non-IBD controls and 20 of 20 (100%) children with
ulcerative colitis. The differences between both affected children
and children with ulcerative colitis versus the non-IBD
controls are statistically significant (p < 0.001).
There is no statistically significant difference between affected
children and those with ulcerative colitis for the proportion of
biopsies showing chronic inflammation (p > 0.1). An
excess of intraepithelial lymphocytes scored positively in eight
of 60 (13%) of affected children, 0 of 22 (0%) non-IBD controls,
and 0 of 20 (0%) with ulcerative colitis. There are no
statistically significant differences between the respective
groups (p > 0.1). Eosinophil infiltration of the lamina
propria was observed in 24 of 60 (40%) affected children, 0 of 20
(0%) non-IBD controls, and four of 20 (20%) with ulcerative
colitis. The difference between affected children and non-IBD
controls is statistically significant (p < 0.001). The
differences between affected children and those with ulcerative
colitis, versus those with ulcerative colitis and non-IBD
controls, are not statistically significant (p > 0.1).
Subepithelial apoptosis/nuclear debris was present in 30 of 60
(50%) affected children, in eight of 22 (36%) non-IBD controls,
and in 16 of 20 (80%) with ulcerative colitis. These differences
are not statistically significant (p > 0.2). Although
not scored prospectively, it was the clear impression of all
reviewing pathologists that, whereas the presence of subepithelial
apoptosis/nuclear debris was a feature of normal biopsies, its
extent was much greater in inflamed biopsies (that is, those from
either affected children or children with ulcerative colitis).

Figure
4
Distribution of histopathological changes in the ileum and colon
(C/A = cecum/ascending, T = transverse, D/S = descending/sigmoid,
and R = rectum) of affected children
compared with controls whose biopsies were reported as normal (non-IBD
controls)
, and children with ulcerative colitis
. The differences between both affected children and those with
ulcerative colitis, and non-IBD controls, for the proportion of
biopsies showing histological change at each site, are
statistically significant (p < 0.001).
 |
Figure
5 (A)
Normal colonic mucosa from a non-inflammatory bowel disease
control child. The surface epithelium is uniform, and the lamina
propria shows loosely organized connective tissue and normal
stratification of cellular density, which characteristically
increases toward the epithelial surface. The demarcation between
lamina propria and epithelial basement membrane is distinct (magnification
×40). (B) Colonic mucosa from an autistic child. There is
mild disruption and lymphocytic infiltration of the surface
epithelium. The crypt epithelium is infiltrated by lymphocytes and
neutrophils. The superficial subepithelial basement membrane is
indistinct compared with (A). The upper two-thirds of the
lamina propria contains an excess of lymphocytes, plasma cells,
and macrophages, with loss of stratification. The matrix of the
lamina propria appears hyaline in nature (magnification ×40). (C)
Crypt abcess formation in a child with autistic enterocolitis (magnification
×100). (D) Crypt distortion in a child with autistic
enterocolitis; bifid crypts are seen to the left and right of the
micrograph (magnification ×100). Micrographs (B-D) come
from different affected children.
Table
2.
Pathological Changes in Biopsies From Affected Children, Children
With Ulcerative Colitis, and Non-IBD Controls
|
|
|
Biopsy
Site
|
Autistic
Enterocolitis (Affected Children)
|
Non-IBD
Controls
|
Ulcerative
Colitis
|
|
No.
of Biopsies
|
No.
Exhibiting Pathology
|
%
|
No.
of Biopsies
|
No.
Exhibiting Pathology
|
%
|
No.
of Biopsies
|
No.
Exhibiting Pathology
|
%
|
|
Ileum
|
52
|
46*
|
88.5
|
20
|
0
|
0
|
14
|
6*
|
42.8
|
|
Cecum/ascending
colon
|
59
|
23*
|
39
|
20
|
1
|
5
|
17
|
14*†
|
82.5
|
|
Transverse colon
|
53
|
33*
|
62
|
20
|
0
|
0
|
17
|
11*†
|
65
|
|
Sigmoid/descending
colon
|
57
|
40*
|
70
|
20
|
0
|
0
|
18
|
17*†
|
94.4
|
|
Rectum
|
60
|
29*
|
48
|
20
|
0
|
0
|
19
|
18*†
|
95
|
|
Total
|
281
|
171*
|
61
|
100
|
1
|
1
|
85
|
66*
| |